Home » Clinical Trials » Therapeutic Areas Therapeutic Areas: Rheumatology | Neurology | Musculoskeletal Disease Category: Fibromyalgia
Trial Information
My FIRBOMYALGIA STILL hurts. Is it time 2-embrace change?
If you have been taking the prescription drug Cymbalta (duloxetine) for at least the last four weeks and are not receiving adequate relief of your fibromylagia symptoms, it may be time to embrace a change. The 2-embrace fibromyalgia study is a switch study to evaluate the safety, tolerability, and effectiveness of the FDA approved prescription drug Savella (milnacipran) in patients experiencing inadequate relief from their fibromyalgia symptoms with Cymbalta.
To qualify for this study you:
Must be an adult of the age of 18 to 70
Have been diagnosed with Fibromyalgia
Have Been treated with a stable dose of Cymbalta (duloxetine) for the treatment of fibromylagia only for at least the last four weeks
Must NOT have participated in a previous Savella or milnacipran clinical research study
If you qualify you will receive all study related medical care, laboratory tests, and study drug at no charge. You do not need health insurance to participate in this study. To see if you might qualify, please call today!
Patient Exclusion Criteria: If you have not been diagnosed with fibromyalgia.
Lynn Tucker, Patient Recruiter
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
